Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2020.00028
Abstract: Acromegaly is a disease due to chronic GH excess and a consequent rise in IGF-1 levels. This rare endocrine condition is associated with metabolic alterations such as hyperglycaemia, dyslipidaemia, and systemic arterial hypertension, which, in… read more here.
Keywords: risk; acromegaly review; review focus; cardiometabolic risk ... See more keywords